Hepion Pharmaceuticals, Inc. (HEPA) stock
HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026Market cap $7.26MP/E –Yield –
Hepion Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Hepion Pharmaceuticals's enterprise value was $1.34M on Oct 19, 2026, against -$2.15M a year earlier. Over the last 5 years it ranged from -$38.06M to $15.44M, with a median of -$2.34M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $1.34M | – |
| 2025 | Dec 31, 2025 | -$1.62M | -191.5% |
| 2024 | Dec 31, 2024 | $1.77M | – |
| 2023 | Dec 29, 2023 | -$6.85M | – |
| 2022 | Dec 30, 2022 | -$36.28M | – |
| 2021 | Dec 31, 2021 | -$11.83M | -295.5% |
| 2020 | Dec 31, 2020 | $6.05M | +65.9% |
| 2019 | Dec 31, 2019 | $3.65M | – |
| 2018 | Dec 31, 2018 | -$10.32M | -172.5% |
| 2017 | Dec 29, 2017 | $14.23M | -77.6% |
| 2016 | Dec 30, 2016 | $63.50M | +94.2% |
| 2015 | Dec 31, 2015 | $32.70M | -33.2% |
| 2014 | Dec 31, 2014 | $48.99M | – |
See a number that looks wrong?